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KAJIAN SITOTOKSIK KE ATAS SEL KANSER PAYUDARA MCF-7 YANG 
DIRAWAT DENGAN EKSTRAK Physalis minima L. 
 
ABSTRAK 
Physalis minima L. dipercayai mempunyai pelbagai aktiviti biologi seperti 
anti-kanser dan anti-oksida. Dalam kajian ini, kesan ke atas pelarut yang mempunyai 
polariti berbeza; heksana (P-Hex), diklorometana (P-DCM), kloroform (CHCl3), n-
butana (P-nBuOH), akues (P-Aq) dan metana mentah (C-MeOH) diuji untuk aktiviti 
anti-kanser ke atas sel  MCF-7. Ekstrak P-DCM menunjukkan sebagai agen anti-
kanser yang berpotensi dengan perencatan 50% pada 24 μg/ml kepekatan dos dan 
ketidaktoksikan ke atas sel normal MCF-10A. Analisis mekanisma kematian sel 
menyifatkan bahawa ekstrak ini telah menginduksi kematian sel berprogram apoptosis 
ke atas sel MCF-7 dengan pembentukan kromatin dan badan apoptotik secara tipikal, 
dimana hal ini merupakan ciri biokimia apoptotis. Peringkat tahap kematian sel 
berprogram apoptosis bersama dengan eksternalisasi phosphatidylserine telah 
dijalankan dengan menggunakan annexin V dan pewarnaan propidium iodide. Selain 
itu, pendedahan akut ekstrak ini terhadap sel MCF-7 telah menghasilkan regulasi 
peningkatan yang ketara kepada ekpresi p53 dan Caspase 8, jadi hal ini mencadangkan 
bahawa laluan ekstrinsik telah terlibat. Selain itu, ekstrak P-DCM telah disemak sifat 
anti-oksidanya. Jumlah kandungan fenolik yang ditemui dalam ekstrak ini telah 
direkod sebanyak 75390 μg gallic asid /g manakala jumlah flavanoid adalah 2480 μg 
kuarcetin /g.  Di samping itu, ekstrak ini merupakan pengurai radikal bebas dengan 
nilai IC50 sebanyak 2.2 µg/mL bagi DPPH dan 8.64 µg/mL untuk ABTS. Toleransi 
positif yang kuat wujud dalam kandungan fenolik dengan aktiviti-aktiviti anti-oksida 
ekstrak P-DCM. Kompoun analisis oleh GC-MS mengesan beberapa potensi sebatian 
xiv 
 
dinamakan; 2-asid propenoik, isomer phytol, 4-undekana, 9-metil-, (Z)-, asid 
heksadekanoik, 2-hidroksi-1-(hidrometil) etil ester, siklododekana, 9,12,15-asid 
oktadekatrinoik, (Z,Z,Z)-, 9,12,15-Oktadekatrinal, n-asid Heksadekanoik, Fenol, 2,5-
bis(1,1-dimetietil)-, asid Phthalic, isobutyl nonil ester and 9,12,15-asid 
Oktadekatrinoik, metil ester, (Z,Z,Z)- manakala dalam analisis LC-TOF-MS, terdapat 
tujuh sebatian telah ditemui iaitu (24E)-15alfa-acetoksi-3alfa-hidroksi-23-oxo-
7,9(11),24-lanostatrien-26-oic asid, 2,6-dikloro-para-fenilenediamin, Natrium 
thiosalicylate, I-Urobilin, Cerberin, Linoleoyl ethanolamide and 5S-HETE-d8.  
Memandangkan terdapat kesan apoptosis ke atas sel MCF-7 and bersifat anti-oksida, 
kajian mencadangkan secara kukuhnya bahawa ekstrak ini disyorkan sebagai salah 
satu alternatif untuk merawat kanser payudara.  
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CYTOTOXICITY STUDY OF MCF-7 BREAST CANCER CELL LINES 
TREATED WITH Physalis minima L. EXTRACT 
 
ABSTRACT 
Physalis minima L. is believed for having a wide range of biological activities 
such as anti-cancer and antioxidant properties. In this study, the effect different 
solvents of several degree of polarities; hexane (P-Hex), dichloromethane (P-DCM), 
chloroform (CHCl3), n-butanol (P-nBuOH), aqueous (P-Aq) and crude methanolic (C-
MeOH) on the anti-cancer activity of MCF-7 cells were studied. P-DCM extract 
exhibited as a potent anti-cancer agent with inhibition of 50% at 24 μg/ml on MCF-7 
cells and non-toxic towards MCF-10A normal cells. Analysis of cell death mechanism 
revealed that the extract induced apoptotic programmed cell death in MCF-7 cells with 
typical chromatin condensation and apoptotic body formation, which are the 
biochemical hallmark of apoptosis. Different stage of apoptotic programmed cell death 
together with phosphatidylserine externalization were established using annexin V and 
propidium iodide staining. Besides that, acute exposure of the extract on MCF-7 cells 
produced a significant up-regulation of p53 and Caspase 8 expression, suggested that 
extrinsic pathway was involved. Besides that, P-DCM extract was examined for the 
antioxidant properties. The total phenolic that contained in the extract was recorded as 
75390 μg Gallic acid equivalents/g while the flavanoids was 2480 μg of Quercetin 
equivalents/g. Moreover, the extract showed as strong scavenger with IC50 value of 
2.2 µg/mL in DPPH and 8.64 µg/mL in ABTS. A strong positive correlation existed 
in respects to the phenolic content with the antioxidant activities of P-DCM extract. 
Compound analysis by GC-MS discovered some possible compounds in P-DCM 
extract named; 2-Propenoic acid, Phytol isomer, 4-Undecene, 9-methyl-, (Z)-, 
xvi 
 
Hexadecanoic acid, 2-hydroxy-1-(hydroxymethyl) ethyl ester, Cyclododecane, 
9,12,15-Octadecatrienoic acid, (Z,Z,Z)-9,12,15-Octadecatrienal, n-Hexadecanoic 
acid, Phenol, 2,5-bis(1,1-dimethylethyl)-, Phthalic acid, isobutyl nonyl ester and 
9,12,15-Octadecatrienoic acid, methyl ester, (Z,Z,Z)- whereas in LC-TOF-MS 
analysis,  there were seven compounds detected  which were (24E)-15alpha-Acetoxy-
3alpha-hydroxy-23-oxo-7,9(11),24-lanostatrien-26-oic acid, 2,6-Dichloro-para-
phenylenediamine, Sodium thiosalicylate, I-Urobilin, Cerberin, Linoleoyl 
ethanolamide and 5S-HETE-d8.  Due to apoptotic effect on MCF-7 cells and 
antioxidant properties, it is strongly proposed that the extract as one of alternative form 
to cure breast cancer. 
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CHAPTER 1 
 
INTRODUCTION 
 
Cancer have become a serious health issue in both developing and developed countries 
(Ma & Yu, 2006; Graidist et al., 2015). According to World Health Organization 
(2018), estimated 9.6 million deaths in 2018 was due to cancer. The most common 
cancers are breast (2.09 million cases), lung (2.09 million cases), colorectal (1.80 
million cases), prostate (1.28 million cases), skin cancer non-melanoma (1.04 million 
cases) and stomach (1.03 million cases) (World Health Organization, 2018). In men, 
the major cancer that attacked them were lung, prostate, colorectal, stomach and liver. 
While in women, breast cancer was the most often cancer followed by colorectal, lung, 
cervix and stomach cancer (American Cancer Society, 2018).  
  
 In Malaysia, 103,507 new cancer cases were diagnosed for the period of 2007- 
2011 according to Malaysia National Cancer Registry Report (Azizah et al., 2016). A 
64.3% was medically certified cancer deaths and non-medically certified cancer death 
was 35.7% (Azizah et al., 2016). The five most common cancers among Malaysian 
residents were breast (17.7%), colorectal (13.2%), lung (10.2%), lymphoma (5.2%) 
and nasopharynx (4.9%). The breast cancer incidence is higher in Chinese and Indian 
women compared to Malay and this differences could be due to reproductive, 
environmental and dietary factors (Yip et al., 2006). 
 
 Breast cancer is mainly treated with surgery, chemotherapy, radiation therapy, 
hormone therapy and targeted therapy (American Cancer Society, 2016). Even though 
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the chemotherapeutic drugs were widely used in treatment of breast cancer and gave a 
positive result in some cases, they have various kind of side effects. These powerful 
agents are highly cytotoxic to almost cells in the body, thus they can destroy some of 
the healthy cells that have a function in dividing and growing for a period of life. The 
post-effect experienced by patients after the chemotherapy session was fatigue, 
infection, anemia, hair loss, bleeding problems, heart problems and lung tissue 
damage.  
 
 The intention and increase in demand of the natural products, specifically the 
usage of medicinal plants was started when bad side effects after chemotherapy 
process had been spread. Thus, the alternative ways to treat the cancer patients is 
needed. The main reason is because the modern treatment has enormously expensive 
and the drugs used had a serious bad side effects and lead to morbidity (Sahdeo et al., 
2012). Estimated 75-80% of the world populations still depend to the herbal medicine 
as the primary health care, especially in developing countries (Ekor, 2013). The 
benefits of alternative treatment that using medicinal plants were more compatible 
with human body, having therapeutic efficacy, not costly and lesser side effects 
(Daniel et al., 2012). 
 
Malay folk community in Malaysia was practiced the medicinal plants such as 
Goniothalamus umbrosus, Typhonium flagelliforme, Myrmecodia pendens, 
Strobilanthes crispus and Clinacanthus nutans in cancer treatment (Ali et al., 2014; 
Wan Afiqah Syahirah et al., 2016). Based on the scientific studies, Malay traditional 
vegetables or locally called ‘ulam’ had reported to kill various types of cancer cells 
such as HeLa, HL-60, MCF-7, K562 and HT-29 (Yih et al., 2012; Tayebeh et al., 2014) 
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as they contained a huge amount of bioactive compounds (Srikanth & Chen, 2016). 
Besides, the decoction of Physalis minima was used for cancer treatment (Zakaria & 
Mohamad, 1994). 
 
P. minima L. is one of the plant that listed as a medicinal plant, believed to 
have an anti-cancer properties (Zakaria & Mohamad, 1994). A few studies were carried 
out abroad have proven the effectiveness of P. minima as an antitumor agent. 
Chloroform extract of P. minima exhibited cytotoxic effect on primary ovarian cancer 
cell line (CaOv-3), human breast carcinoma cell line (T-47D) and human lung 
adenocarcinoma cell line (NCI-H23) (Ooi et al., 2010(a); Ooi et al., 2010(b); Ooi et 
al., 2011). Besides that, P. minima methanolic extract also showed anti-cancer activity 
towards cervical cancer cell line (HeLa) and epithelial cell line (HEp-2) 
(Krishnakumar & Chauhan, 2016). However, there is still lack of information on the 
activity of this plant towards the MCF-7 breast cancer cells. Thus, the focus of present 
study is to access the anti-cancer activity of various solvent extract of P. minima 
together with its phytochemical contents. This approach was chosen in order to 
produce the quality standardization data and reference guidelines towards the 
development of P. minima as potential anti-cancer agent in the future.  
 
1.1 RESEARCH QUESTION 
1. Which P. minima extract give cytotoxic effect on MCF-7 breast cancer 
cell line? 
2.  Which apoptosis pathway does MCF-7 breast cancer cell line follow 
after treated with P. minima extract? 
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1.2 HYPOTHESIS 
Ho: P. minima extract has no cytotoxicity effect on MCF-7 breast cancer cell 
line 
H1: P. minima extract possess cytotoxicity activity on MCF-7 breast cancer cell 
line and express apoptotic related protein 
 
1.3 OBJECTIVES 
The objectives of this study are: 
1. to compare the cytotoxicity effect of hexane (P-Hex), dichloromethane 
(P-DCM), chloroform (P-CHCl3), n-butanol (P-nBuOH) , aqueous (P-
Aq) residue and crude methanolic (C-MeOH) extract of P. minima on 
MCF-7 breast cancer cell 
2. to evaluate the anti-cancer properties of P. minima extract on MCF-7 
breast cancer cell line through apoptosis and Western blot analysis 
3. to determine the phytochemical profiling of P. minima extract using 
antioxidant assay, GC-MS analysis and LC-TOF-MS analysis 
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CHAPTER 2 
 
LITERATURE REVIEW                               
 
2.1 An overview of breast cancer  
The non-stop cells dividing will lead to cancer (Rajeswari et al., 2012). Cancer that 
develops from the breast tissues is called as breast cancer. It was reported as the most 
common cancer occurred in women worldwide (Lim & Halimah, 2008; Maznah et al., 
2011). There are estimated 1.38 million new breast cancer cases were diagnosed in 
2008 (Curado, 2011). In most of the Asian countries i11ncluding Malaysia, the 
occurrence of breast cancer was reported to be increasing from year 2006 and above 
(Medina et al., 2010; Park et al., 2011). It is still conquered as the top health problem 
in all ethnics in Malaysia as reported by Abdullah et al., (2013). 
 
2.1.1 The biology of breast cancer 
From the distinct features of breast cancer, the lifetime risk can be determine. Besides, 
the overall prognosis after a diagnosis of breast cancer and the possibility of response 
to specific therapy also can be analyze. In addition, the deep understanding of breast 
cancer pathways may help peoples to plan their targeted approaches. Various factors 
that caused the growth of the breast cancer and its progression including certain steroid 
receptors (estrogen receptor [ER], progesterone receptor [PR] and retinoic acid 
receptor-ß), members of the HER/erbB family and selected tumor suppressor or 
susceptibility genes (p53, BRCA1, and BRCA2) ( Judith & Nancy, 2003). Thus, the 
biology of breast cancer can contribute vital information regarding many aspects of 
the disease.   
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Breast cancer can be divided into two types based on the cell’s formation under 
the microscope which are carcinomas and sarcomas (Rodney & John, 2003). 
Carcinomas breast cancer started in epithelial cells of breast where sarcomas are 
started in the cells of muscle, fat or connective tissues of the breast. But, there is a rare 
type of breast cancer where the breast was inflamed and looked red, swollen and feel 
warmed. There are four stages reported in breast cancer (Sepideh et al., 2015).  Stage 
one is the earliest detection of breast cancer development. At this stage, the production 
of the cancer cells are very limited. In stage two, the cancer cells have a tendency to 
grow or metastasize. Stage three considered as advanced cancer, where it had invaded 
the neighboring tissues. In stage four, the cancer cells had spread throughout other 
parts of the body. 
 
2.1.2 Modern treatment of breast cancer 
Breast cancer can be treated with local and systemic treatments depending on the type 
of the breast cancer (American Cancer Society, 2016).  Local treatment can be divided 
into surgery and radiation therapy. There are two types of surgery, which are breast-
conserving surgery and total mastectomy. Breast-conserving surgery is a process of 
removing the tumor and nearby margin only from the patient’s body while, total 
mastectomy is the process removing the whole breast that was confirmed having a 
cancer. Radiation therapy usually used x-rays or particles radiation. For systemic 
treatments, they consist of chemotherapy, hormone therapy and targeted therapy. 
Chemotherapy used the anti-cancer drug to destroy the cancer cells (Henry et al., 2013) 
while, hormone therapy involved hormone to slow or stop the cancer growth. 
Meanwhile, targeted therapy used anti-cancer drug but it focused on specific gene or 
protein to stop the cancer.  
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However, there are more than 500 antagonistic effects that related with modern 
cancer treatments have been compiled including minor effect up to life threatening 
injuries (Wang et al., 2006).  Thus, alternative therapies using medicinal plants have 
been developed for centuries to treat the cancer (Schröder et al., 2013). Approximately 
6 out of 10 peoples with cancer in United Kingdom used natural remedies together 
with alternative cancer therapies as it is effective, affordable, easy and simple to 
prepare (Ling et al., 2014). 
 
2.2 Medicinal plants   
Medicinal plants had been recognized for centuries in having anti-cancer properties. 
Based on the data obtained from The National Cancer Institute (NCI), nearly 35,000 
plant species from 20 countries had been screened for potential anti-cancer activities 
(Desai et al., 2008). The demand of the medicinal plants was increased from time to 
time as it showed non-toxic effects towards normal cells and had cytotoxic effects on 
cancer cells. Many plant species that investigated as herbal therapy were selected from 
developing countries in Asia, where peoples there relied on medicinal plants as a 
primary treatment (Ochwang'i et al., 2014). Some of the herbal plants that have been 
used in cancer treatment were listed in Table 2.1. 
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Table 2.1. Example of herbal plant used in cancer study
Plant materials Solvent extraction  Cell line Region Phytochemicals 
content 
Reference 
Physalis minima Chloroform 
Methanol 
CaOv-3 
T-47D 
NCI-H23 
HeLa 
HEp-2 
Malaysia Physalin F Ooi et al., 2010(a); 
Ooi et al., 2010(b); 
Ooi et al., 2011 
Krishnakumar & 
Chauhan (2016) 
Echinacea purpurea Aqueous ethanol  Caco-2 
HCT-116 
Taiwan Cichoric acid Tsai et al., (2012) 
Synsepalum dulcificum Methanol  
Ethanol 
HCT-116 
HT-29 
Philippines Phenolics, 
carotenoids 
Seong et al., (2018) 
Curcuma longa Methanol HeLa India Alkaloid,  
flavanoids, phenolics 
Shukla et al., (2016) 
Azadirachta indica Methanol HeLa India Alkaloid,flavanoid, 
tannins, saponins, 
phenolic, glycoside 
Shukla et al., (2016) 
Piper cubeba Methanol MDA-MB-468 Thailand Phenolic Graidist et al., (2015) 
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2.3 Physalis minima 
This study is focusing on P. minima. It belongs to Physalis genus and Solanaceae 
family (Burkill et al., 1966; Ganapathi et al., 1991). Figure 2.1 shows the taxonomic 
rank of P. minima. The genus Physalis L. consisted of 120 species scattered all over 
the world (Navdeep et al., 2015). P. minima is one of the species that became famous 
among researchers nowadays as it was believed to have medicinal values. Cape 
gooseberry, bladder cherry, pygmy ground cherry and ‘letup-letup’ is a common name 
for the plant. It is also known as P. eggersii O.E. Schulz, P. lagascae Roem. & Schult, 
and P. lagascae var. glabrescens O.E. Schulz (Navdeep et al., 2015). According to 
Chotani and Vaghasiya (2012) and Integrated Taxonomic Information System (ITIS) 
(2015) report, it is widely distributed in tropics regions such as India, Baluchistan, 
Afghanistan, Tropical Africa, Singapore, Australia and Malaysia, yet it was probably 
originated from neotropics. 
 
 
Taxonomic hierarchy of P. minima 
    Kingdom  : Plantae 
Order  : Solanales 
Family  : Solanaceae 
Genus : Physalis 
Species  : Physalis minima 
  
 
 
      Figure 2.1. Taxonomic rank of P. minima 
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2.3.1 Botanic description of Physalis minima 
P. minima is annual plant having a weedy stem and usually grew at disturbing sites 
especially on sandy to gravelly soil (Azlan et al., 2002). It has been classified in 
dicotyledonous group. It can reach up to 0.5-1.5 m height with a purple-tinged stem 
(Figure 2.2). It has ovate leaves with 9.7 m long and 8.1 m broad. Its corolla is 
yellowish with no coloration inside and less than 6 mm in diameter (Figure 2.3). It has 
a yellow berry-like fruit with oblong-ovoid in shape, 0.8-1 cm in diameter and 
enclosed in calyx (Figure 2.4) (Reddy et al., 1999; Nathiya & Dorcus, 2012). The 
shape of the seeds is suborbicular-oblong and 2 x 1.8 mm diameter (Reddy et al., 
1999). 
 
   
Figure 2.3. Corolla of P. minima Figure 2.2. The P. minima plant 
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                                    Figure 2.4. Fruits of P. minima 
 
2.3.2 Traditional uses of Physalis minima 
P. minima has been used since long time ago as a remedy for headache and fever 
(Panda, 2000; Agbor & Ngogang, 2005; Pullaiah, 2006). Spleen disorders, wound 
pustules, intestinal pains, purgative, diuretic and gonorrhea also have been treated with 
this plant (Chopra et al., 1969; Parmar & Kaushal, 1982; Karthikeyani & Janardhanan, 
2003; Raju et al., 2007; Anisuzzaman et al., 2007; Khare, 2007; Dilip et al., 2008). 
Besides that, it has been used to restore the flaccid breasts, treatment of colic and 
gastrophy (Burkill et al., 1966; Sethuraman & Sulochana, 1988; Gupta et al., 2010). 
This plant appetizing bitter, thus peoples used it as a tonic for inflammation, spleen 
enlargement and abdominal problems (Vipin & Ashok, 2010). The fruits and flowers 
of P. minima was believed to cure stomach pain, constipation and ear troubles, while 
the root part was used for treatment of backache and odeama (Vipin & Ashok, 2010). 
Interestingly, the whole plant was practiced by the Malay community in Peninsular 
Malaysia for cancer treatment (Zakaria & Mohamad, 1994). 
 
 
 
12 
 
2.3.3. Pharmacological effects of Physalis minima 
P. minima possessed beneficial health properties as reported scientifically. The current 
research towards P. minima is extremely being carried worldwide in order to assess 
the importance of the plant in terms of therapeutic value. A research on methanolic 
extract of P. minima leaves was reported to possess the diuretic effect in albino Wister 
rats (Jyothibasu, 2012). The doses of the methanolic extract of P. minima (MEPM) 
was set at 100 and 200 mg/kg, p.o. The quantity of urine was significantly increased 
with both doses. The sodium and potassium excretion in Wister rats also were 
increased by the MEPM and it was suggested that the extract produce significant effect 
in diuretic activity.  
 
In addition, the gastric ulcer treated with P. minima methanolic extract has been 
investigated. The anti-ulcer activity was assessed on ethanol induced ulcer models and 
pylorus ligation in Wister rats by using MEPM. The acute gastric ulcer was prevented 
with the dosage of 100 and 200 mg P. minima per kg body weight, in two times per 
day for five days.  The gastric volume, free acidity, total acidity and ulcer index were 
significantly reduced by MEPM, indicated that it had the healing action of chronic 
ulcer (Jyothibasu et al., 2013).  
 
Another study on P. minima reported that its ethanolic extract possessed 
hepatoprotective activity on paracetamol induced hepatic injury rats (Pratheeba et al., 
2014). There are significantly increased in aspartate aminotransferase (SGOT) at 
212U/L, alanine aminotransferase (SGPT) at 320 U/L and Serum Bilirubin at 0.8mg/dl 
on paracetamol treated rats when compared to silymarin, a standard hepatoprotective 
drug. Besides that, aqueous soxhlet extraction of P. minima was tested in-vitro on 
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alloxan-induced diabetic albino rats to determine the hypoglycemic effects (Sucharitha 
& Estari, 2013). The root and stem parts of P. minima exhibited mild reduction in 
fasting blood glucose level. While, its leaves and flowers revealed a significant 
decreased in blood glucose level of fasting rats. Thus, the study indicated that both 
leaves and flowers extract of P. minima had higher efficiency and potent anti-diabetic 
agent than root and stem extract.  
 
Anti-microbial activity treated with P. minima has been examined before. 
Nathiya and Dorcus (2012) worked on various bacterial strains which are Bacillus 
cereus, B. subtilis, Citrobacter sp., Enterobacter aerogene, Escherichia coli, 
Klebsiella pneumonia, Pseudomonas aeruginosa, P. fluorescens and Staphylococcus 
aureus that treated with chloroform, diethyl ether, ethanol, ethyl acetate and methanol 
extract of stem, leaf and unripe fruits of P. minima.  B.cereus, E. aerogene and S. 
aureus had greater antibacterial activity with maximum inhibition zone (10.0 mm ± 
0.5) in ethanol extract, suggested that ethanol was found to be more effective compared 
to other solvents used. 
 
Moreover, P. minima has been used in the prevention of cancer disease. The 
chloroform extract of P. minima plant was treated on human lung adenocarcinoma 
NCI-H23 cell lines. The extract showed the time- and dose-dependent manner and 
induced apoptosis with typical DNA fragmentation. The extract also significantly 
regulated c-myc, caspase-3 and p53 mRNA expression in NCI-H23 (Ooi et al., 2011). 
In T-47D breast carcinoma cell lines, the chloroform extract of P. minima exerted 
programmed cell death via p53-, caspase-3-, and c-myc-dependent pathways (Ooi et 
al., 2010(b)). The extract also exhibited cytotoxic on CaOv-3 human ovarian 
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carcinoma. The cells experienced the combination of apoptosis and autophagic 
mechanism (Ooi et al., 2010(a)). Besides that, MEPM showed the increment of growth 
inhibition percentage in both HeLa and HEp-2 cell line through SRB and MTT assay.  
 
2.4 Phytochemistry study of natural product 
Chemotaxonomy is an application of chemical data to systematics. It has become a 
great attention among biochemists and botanists in development of natural products. 
To detect the various group of naturally occurring phytochemicals, some 
phytochemical investigations have been carried out. This approach considered 
effective in determining the bioactive profile of plants for beneficial value (Masih & 
Singh, 2012). 
 
2.4.1 Gas Chromatography-Mass Spectrometry (GC-MS) 
The discovery of the electron has been started since 1897, which was happened after 
the information on electrical discharges in gases was developed by Sir J. J. Thomson. 
After that, the innovation of first mass spectrometer (MS) was started in order to 
quantify the mass-to-charge ratios of ions. Before this, it was known as parabola 
spectrograph. The potential actions by MS were reported throughout 100 years, which 
involved the isotopes discovery, actual atomic weight determination, classification of 
new element, quantitative gas analysis, stable isotopes identification and the 
characterization of molecular structure. 
 
GC-MS approach in herbal medical plant research is unable to be challenged. 
A study on identification and quantification of active natural compound in methanol 
extract of tea was made possible by GC-MS. The major biologically active constituents 
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identified include caffeine, ß-sitosterol, ß-amyrin, lupeol, linoleic acid and vitamin E 
(Novotny et al., 2015).  
 
2.4.2 Liquid chromatography/time-of-flight mass spectrometry (LC-TOF-MS) 
Liquid chromatography paired to mass spectrometry is a powerful technique to analyze 
various components in complex herbal matrices especially for qualitative applications 
(Zhou et al., 2009). LC-TOF-MS produced good analysis through its high resolution, 
specific molecular mass information and offered good linearity over a large dynamic 
range (Macherone et. al., 2018).  
 
 LC-TOF-MS analysis of extract from roots of Gentiana macrophylla was done 
by Qi et al., (2012). There were eight major peaks detected, including four secoiridoid 
glucosides group and four unknown compounds. The secoiridoid glucosides group 
consisted of loganic acid (mass = 375.3), 6′-O-β-D-glu-gentiopicroside (mass =553.4), 
swertiamarin (mass = 409.3) and gentiopicroside (mass = 391.3). The unknown 
compounds obtained possibly due to its extremely low content.  
 
2.5 Cell death mechanism 
The greatest phenomenon during the development of multicellular organism is a 
programmed cell death or called apoptosis (Kroemer et al., 2009). Apoptosis removed 
the unnecessary or potentially harmful cells in multicellular organism in normal 
physiology (Castro-Obregon et al., 2004).  
 
Apoptosis can be seen with typical morphological structure changes where the 
cells will lost their integrity, shrinkage of cell, nuclear condensation or karyorrhexis, 
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forming a nucleosomal fragments from accumulation of chromatin, cell fragmentation, 
leaking in mitochondria, membrane blebbing and formation of apoptotic bodies 
(Kroemer et al., 2009). Once the apoptotic bodies formed, the neighboring cells 
engulfed it rapidly without any inflammatory response (Wiegand et al., 2001). 
Apoptosis has two main pathways which are mitochondria pathway (intrinsic) and 
death receptor pathway (extrinsic) (David et al., 2013). Figure 2.5 shows an 
illustration of mitochondria pathway and death receptor pathway. 
 
 
 Figure 2.5. Illustration of mitochondria and death receptor pathway 
(Hengartner, 2000) 
  
2.5.1 Mitochondria pathway (intrinsic) 
The cellular stress like DNA damage, cell exposed to heat and radiation, viral 
infection, free radicals that caused oxidative stress to cells were initiated the 
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mitochondria pathway. The cellular stress resulted the pro-apoptotic protein of Bcl-2 
family bound to the outer membrane of the mitochondria. A pro-apoptotic factor, Bax 
translocated from cytosol to outer mitochondria membrane and protein-lined channel 
was created. The released of intracellular content and cytochrome C from the 
mitochondria were promoted by the pro-apoptotic proteins through the protein-lined 
channel (Vladimir et al., 2006).  
 
 The cytochrome C is a main regulator in this pathway. Once it was released 
out from the mitochondria, the cells undergo irreversible to death. Then, it combined 
with adenosine triphosphate (ATP), enzyme called Apaf-1, and pro-caspase-9 to 
produce apoptosome in the cytoplasm. Apaf-1 induced the conformational change in 
pro-caspase-9 and became activated caspase-9. The caspase-9 activated the caspase-3, 
which is the effector protein, thus causing caspase cascade and degradation of cells 
(Peng et al., 2011).  
 
Generally, Bcl-2 proteins family are the important regulator of apoptosis 
incidence in this pathway. The caspase cascade activation and process of cytochrome 
C discharging out from the mitochondria body was regulated by the anti-apoptotic 
members of Bcl-2 family proteins such as Bcl-X, Mcl-1 and Bcl-w and also pro-
apoptotic members like Bax, Bak, Bad, Bid and Bok.  
 
2.5.2 Death receptor pathway (extrinsic) 
The death receptor pathway was initiated by extracellular ligands or sometimes by the 
removal of growth factor. Ligand like tumor necrosis factor (TNF) bound with its 
receptor, TNFR-1 caused conformational change in death domain.  The death domain 
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was activated when two cytosolic adaptor protein (FADD and TRADD) and 
procaspase-8 bound together. The interaction between both procaspase-8 and FADD 
was generated an active caspase-8, initiator protein. The role of caspase-8 is similar to 
the caspase-9 that involved in intrinsic pathway, where it activated caspase-3 to start 
the degradation process (David et al., 2013). 
 
2.6 Molecular analysis of herb extract on cancer cell  
The mechanisms of herb extract on cancer cell can be understand by molecular 
analysis such as genomic, transcriptomics and proteomic approach.  
 
2.6.1 Genomic analysis  
DNA level is very basic cellular level that is common to many cancers. Cancer caused 
by DNA alteration of nucleotide sequence of the genome to enable the cell to 
proliferate in an unregulated manner (Hyndman, 2016; Ruth, 1997). It also called as 
somatic mutation (Nik-Zainal & Morganella, 2017). Stratton et al., (2009) stated that 
the mutation usually occurred during the cell division stage where the gene has been 
damaged or lost or replicated. DNA replication involved insertion and deletion of 
nucleotides (Stratton et al., 2009).  This error caused the cell to stop its normal function 
and started to grow out of control (Hyndman, 2016). 
 
2.6.2 Transcriptomics analysis 
The study at RNA level is called transcriptomics analysis. Researchers have been used 
transcriptomics analysis for their understanding in cancer research. Jing et al., (2005) 
used DNA microarray to investigate the influence of the Coptidis rhizoma extract on 
appearance of the mutual cancer genes involved in human breast cancer cell lines, the 
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ER-positive MCF-7 and ER-negative MDA-MB-231 cells. From this assay, they 
revealed that MCF-7 treated with C. rhizoma extract dramatically upregulated the 
mRNA expression of interferon- β (IFN- β) and tumor necrosis factor-α (TNF- α). The 
changes in mRNA expression was confirmed by real time PCR (RT-PCR) analysis, 
showed that the extract increased  IFN- β and TNF-α expression for ~200-fold and 17-
fold, respectively. Since IFN- β as an important anticancer cytokines, it played the 
responsible in antiproliferative effect in MCF-7 treated with C. rhizoma extract (Lee 
& Margolin, 2011). 
 
Kuo-Hua et al., (2018) also investigated the effect of shikonin extracted from 
dried root of Lithospermum erythrorhizon on different types of breast cancer cells 
lines, MCF-7, SKBR-3 and MDA-MB-231 through transcriptome analysis using 
RNA-seq. From RNA-seq transcriptome analysis, there are 38 common genes were 
expressed in different types of breast cancer. Among them, 36 common genes were 
consistently upregulated, one gene was downregulated and the only one gene RN7SL1 
was inconsistently expressed. A qRT-PCR was done using five randomly selected 
genes (DUSP1, DUSP2, CDKN1A, SESN2, PGF) to validate the result of RNA-seq 
analysis. There are high correlation between expression ratio of RNA-seq and qRT-
PCR. After the shikonin treatment, the expression of DUSP1 and DUSP2 was 
increased in all types of cancer cell lines. Therefore, the extract might be a therapeutic 
alternative medicine for treating cancer as there are induction in DUSP1 and DUSP2, 
the upstream regulator of MAPK signaling pathway.  
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2.6.3 Proteomics analysis  
Proteins work as a main functional unit in the cell and the major target of most drugs. 
Unfortunately, the expression levels, modifications and functions of protein were 
poorly attributed by genomic and transcriptomics analysis (Zhao et al., 2017). 
Proteomics analysis is a study that involved proteins. Zejun et al., (2014) was studied 
the proteomic analysis of lung cancer cells treated with periplocin. To analyze the 
protein profile in human lung cancer cell lines A549, they had performed the 2-DE 
combined with MS/MS and validation was done through Western blotting analysis. 
From 2-DE profiling, 53 protein spots were found to express differently in periplocin- 
and NS-treated A549 cells. There were 39 proteins were recognized by MS/MS, where 
29 of them were downregulated and the rest were upregulated by periplocin activity. 
Based on Western blotting analysis, the proteins EIF5A, PSMB6, ATP5A1 and 
ALDH1 were downregulated when treated with periplocin, which is correlated with 2-
DE analysis.  
 
 Another study on proteomics analysis of human colon cancer cell line, HT-29 
treated with 20S-Ginsenoside-Rg3 was done by Lee et al., (2009). In 2DE, a 17 cm pH 
4-7 linear IPG strips were used to examine the protein expressions in HT-29 cell line. 
There were 20 spots with different expression in treated and untreated 2D image by 
PDQuest software. Eight out of 20 spots identified were significantly different (p < 
0.05), as they exhibited increased or decreased the spots intensities more than 2-folds 
when compared with control. By using MALDI-TOF/TOF-MS and NCBI database, 
five proteins (retinoblastoma binding protein 4, clathirin, tropomyosin 1, annexin 5, 
glutathione S-transferase-P1c) were upregulated and three proteins (serine, PCNA, rho 
GDP dissociation inhibitor alpha) were down-regulated. Retinoblastoma binding 
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protein 4 and clathirin were proteins related to mitosis inhibition, while rho GDP 
dissociation inhibitor alpha, tropomyosin 1 and annexin 5 were proteins that involved 
in apoptosis. The proteome changes correlated with mitosis inhibition, DNA 
replication and repair and growth factor signaling in HT-29. They concluded from the 
proteomics data obtained, there were various mechanisms for anti-cancer effect in HT-
29 when treated with 20S-Ginsenoside-Rg3 (Lee et al., 2009). 
  
In addition, Nagappan et al., (2016) have been studied the anti-cancer effect of 
A549 human lung cancer cells treated with flavanoids isolated from Citrus 
platymamma (FCP) using a proteomics approach. The flavanoids exhibited cytotoxic 
effect on A549 cell line and no cytotoxic activity was determined in WI-38 human 
fetal lung fibroblasts. From the proteome analysis of 2DE, 15 protein spots were 
expressed with intensities ≥ 2-fold change at p < 0.05 compared to control. The matrix-
assisted laser desorption/ionization time-of-flight/time-of-flight tandem mass 
spectrometry and peptide mass fingerprinting analysis has been identified eight 
differently expressed protein, where one of which was upregulated and the rest were 
downregulated. The annexin A1 and annexin A4 proteins were downregulated whereas 
the 14-3-3ɛ protein was upregulated.  These proteins were involved in signal 
transduction. There were downregulated in cytoskeletal proteins (cofilin-1, cytokeratin 
8 and cytokeratin 79) and molecular chaperones proteins (endoplasmin) together with 
elongation factor Ts, which is the protein involved in protein metabolism. Most of the 
proteins were involved in tumor growth, cell cycle, apoptosis, migration and signal 
transductions. Thus, they suggested that the proteomic findings contributed the 
information of molecular mechanism underlying the anti-cancer effects of A549 cells 
treated with FCP. 
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CHAPTER 3 
 
RESEARCH METHODOLOGY 
 
3.1 Introduction 
This chapter will be discussed about the materials, chemicals, reagents and 
methodology used in this study. This research has been divided into two major features 
to validate the potential of P. minima extracts. The methodology have been divided 
into two part; Part I: Anticancer study and Part II: Phytochemical screening. This 
study was conducted in Molecular Biology Laboratory, Integrative Medical Cluster, 
Advanced Medical and Dental Institute, Universiti Sains Malaysia. Table 3.1 shows 
the chemicals and reagents, while the tools and apparatus used in this study are listed 
in Table 3.2. 
 
Table 3.1 List of chemicals and reagents 
Study  Chemicals and reagents Supplier 
 Acrylamide (30% w/v) Bio-Rad, USA 
 Ammonium persulphate (AP) Bio-Rad, USA 
 Annexin V-FITC Kit Miltenyi Biotec, 
Germany 
 Beta-mercaptoethanol / 2-
Mercaptoethanol (β-ME) 
Sigma-Aldrich, USA 
 Bradford 1X Dye Bio-Rad, USA 
Anti-cancer Bromophenol blue Bio-Rad, USA 
 CellTiter 96® AQueous One Solution 
Cell Proliferation Assay (MTS) 
Promega, USA 
 Chloroform Merk, Germany 
 Dichloromethane  Merk, Germany 
 Dimethyl sulphoxide (DMSO) Merk, Germany 
 Dulbecco Modified Eagle’s Medium 
(DMEM) 
GIBCO, BRL, UK 
 ECL™ Prime Western Blotting 
Detection Reagent 
Bio-Rad, USA 
 Epidermal Growth Factor (EGF) GIBCO, BRL, UK 
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 Ethanol Merk, Germany 
 Glycerol Amresco, USA 
 Glycine Vivantis, USA 
 Goat polyclonal Secondary Antibody to 
Rabbit IgG – H&L (HRP) 
Cell Signaling 
Technology, Inc. 
 Heat-inactivated fetal bovine serum 
(FBS) 
GIBCO, BRL, UK 
 Hexane Merk, Germany 
 Horse Serum GIBCO, BRL, UK 
 Hydrochloric acid  Merk, Germany 
 Hydrocortisone GIBCO, BRL, UK 
 Insulin GIBCO, BRL, UK 
 Methanol  Merk, Germany 
 n-Butanol Merk, Germany 
 N,N,N’,N’-tetramethylethylenediamine 
(TEMED) 
Bio-Rad, USA 
 Penicillin/streptomycin stock solution 
(PenStrap) 
GIBCO, BRL, UK 
 Phosphate-buffered saline (PBS) Amresco, Australia 
 Precision Plus Protein™ All Blue 
Prestained Protein Standards  
Bio-Rad, USA 
 Protease inhibitor cocktail Bio-Rad, USA 
Anti-cancer Potassium chloride Sigma-Aldrich, USA 
 Rabbit anti-human β-actin polyclonal 
IgG 
Abcam, UK 
 Rabbit anti-human Bax polyclonal IgG Abcam, UK 
 Rabbit anti-human caspase-8 polyclonal 
IgG 
Abcam, UK 
 Rabbit anti-human cytochrome c 
polyclonal IgG 
Abcam, UK 
 Rabbit anti-human p53 polyclonal IgG Abcam, UK 
 RIPA Buffer Bio-Rad, USA 
 Roselle’s Park Memorial Institute  
Media (RPMI-1640)  
GIBCO, BRL, UK 
 Skimmed milk powder SunLac, Malaysia 
 Sodium chloride Sigma-Aldrich, USA 
 Sodium dodecyl sulphate powder Bio-Rad, USA 
 Tamoxifen Citrate Salt Nacalai tesque, Japan 
 Tris base Vivantis, USA 
 Trypan blue  Sigma-Aldrich, USA 
 Trypsin (0.25%, w/v)/EDTA  GIBCO, BRL, UK 
 Tween-20  Amresco, USA 
 Quick Stat Bovine Serum (BSA) Bio-Rad, USA 
 1.0 M Stacking gel buffer Bio-Rad, USA 
 1.5 M Resolving gel buffer Bio-Rad, USA 
 30% (w/v) Acrylamide/Bis solution Bio-Rad, USA 
 Acetonitrile Merk, Germany 
 Aluminium chloride Acros Organics, USA 
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 Folin Merk, Germany 
 Formic acid  Merk, Germany 
 Gallic acid Acros Organics, USA 
Phytochemicals Potassium persulfate Sigma-Aldrich, USA 
Screening Quercetin Acros Organics, USA 
 Sodium carbonate Sigma-Aldrich, USA 
 Trolox Sigma-Aldrich, USA 
 2,2’-Azinobis(3-ethylbenzothiazoline-6-
sulphonic Acid) ABTS 
Sigma-Aldrich, USA 
 2,2-Diphenyl-1-picrylhydrazyl (DPPH) Sigma-Aldrich, USA 
 
Table 3.2 List of tools and apparatus 
Tools and apparatus Supplier 
Analytical balances  Sartorius, Germany 
Automated cell counter Bio-Rad, USA  
Agarose gel electrophoresis apparatus Bio-Rad, USA 
Belly dancer Stovall Life Science, Greensboro 
Biomate spectrophotometer Thermo  Fisher Scientific, USA 
Biosafety Cabinet Class II ESCO Global, Singapore 
Blender Panasonic 
Centrifuge tube (15 mL and 50 mL)  Thermo Fisher Scientific, USA 
Cell scrapper Cell Biologic, Chicago 
Chamber slides Bio-Rad, USA 
Cryogenic vials and Cryoboxes Nalgene, USA 
Culture flasks and dishes Nunc, Denmark 
Filter paper Bio-Rad, USA 
Filter paper (Whatman®) Schleicher & Schuell, USA 
Flow cytometer (FACS Calibur) Becton Dickinson, USA 
Freeze Dryer (GENEVAC LTO, EZ 2.3 
ELITE) 
SP Scientific 
Gas chromatograph (GC)7890A Agilent, USA 
Heraeus Megafuge 16 Centrifuge Thermo  Fisher Scientific, USA 
Humidified CO2 incubator Thermo  Fisher Scientific, USA 
Inverted microscope CKX41 OLYMPUS, USA 
Ice flakes machine SASTEC, Malaysia 
LC-TOF-MS machine 2795 Waters, USA 
Mass spectrometer system (MS) 5973 
inert MSD 
Agilent, USA 
Microcentrifuge (Minispin plus) Hitachi, Japan 
Microplate Reader BMG LABTECH, Germany 
Molecular Imager VersaDoc ™ MP 
4000 
Bio-Rad, USA 
Mechanical pipette BD Falcon™, USA 
Micropipette tips (1 µl, 10 µl, 200 µl 
and 1000 µl) 
Axygen® Scientific, USA 
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Polyvinylidene fluoride transfer 
(PVDF) membrane 
Axon Scientific, Malaysia 
Refrigerator Haier Haier America 
Rotary Evaporator (EYELA, N1100) Tokyo Rikakikai Co., LTD. 
Semi-dry Transfer Cell (Transblot® 
SD) 
Bio-Rad, USA 
Serological pipettes (10 mL and 25 mL) Nunc, Denmark 
Shaker (Orbitos) Infors HT, Switzerland 
Syringe Terumo Medical Corporation 
Syringe membrane filter (0.22 µm) Jet Bio-Filtration, China 
Water bath  Jeio Tech Co., Ltd., South Korea 
Western blot (PowerPac™ Basic) Bio-Rad, USA 
24-well culture plates Nunc, Denmark 
3 Systems Glass Plates (Mini 
PROTEAN®) 
Bio-Rad, USA 
96-well microtiter plates Nunc, Denmark 
 
3.2 Preparation of 80% MeOH Physalis minima leaves extract  
P. minima L. was harvested from Kepala Batas, identified and washed with distilled 
water. The plant was submitted to the USM Herbarium for species identification 
through morphological taxonomy by Dr Rahmad Zakaria with voucher number 11723 
(APPENDIX 1). A 200 g weight of leaves were ground finely with 300 mL of distilled 
water using a mechanical grinder. A 1200 mL of methanol (MeOH) was added, shaken 
with shaker at 250 rpm and filtered with Whatman #1 filter paper for every 24 hours 
within three days. Then, the solvent was removed by using the Rotary Evaporator at 
140° hPa; 60°C; speed 5 (APPENDIX 2) and subjected to freeze dry for a week 
(APPENDIX 3) to obtain dry form of P. minima extract. The dried crude 80% MeOH 
extract (C-MeOH) obtained was weighed using an analytical balances and stored at -
20°C until use. 
 
 
 
